Regeneron Pharmaceuticals Inc. (REGN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Regeneron Pharmaceuticals...

    NASDAQ: REGN · Real-Time Price · USD
    573.38
    6.16 (1.09%)
    At close: Sep 05, 2025, 3:59 PM
    571.99
    -0.24%
    After-hours: Sep 05, 2025, 07:50 PM EDT

    Regeneron Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 4.41B 3.95B 4.34B 8.08B
    Depreciation & Amortization
    		 482.9M 421M 341.4M 286.2M
    Stock-Based Compensation
    		 982.8M 885M 725M 601.7M
    Other Working Capital
    		 -179.7M -82.2M -116.2M -360.9M
    Other Non-Cash Items
    		 -82.2M 266.3M 599.8M 181.7M
    Deferred Income Tax
    		 -757.3M -837.8M -746.4M -147.1M
    Change in Working Capital
    		 -618.3M -94.1M -243.3M -1.92B
    Operating Cash Flow
    		 4.42B 4.59B 5.01B 7.08B
    Capital Expenditures
    		 -755.9M -926.4M -590.1M -551.9M
    Cash Acquisitions
    		 -16.5M -54.9M -230.3M 551.9M
    Purchase of Investments
    		 -16.62B -11.65B -7.49B -7.05B
    Sales Maturities Of Investments
    		 15.03B 9.44B 5.55B 2.22B
    Other Investing Acitivies
    		 -105.6M n/a -1.03B -551.9M
    Investing Cash Flow
    		 -2.47B -3.19B -3.78B -5.38B
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 -3.63B -2.94B -2.53B -2.68B
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -33.4M n/a -445.7M -1.03B
    Financial Cash Flow
    		 -2.2B -1.79B -1.01B -1.01B
    Net Cash Flow
    		 -248.8M -381.6M 221.3M 690.8M
    Free Cash Flow
    		 3.66B 3.67B 4.42B 6.53B

    Add to Watchlist